The authors designed PEGylated lipid nanoparticles loaded with a non-opioid analgesic, bupivacaine, to target neurons within breast cancer tumors and suppress nerve-to-cancer cross-talk.
[Science Advances]
7992332
{7992332:CCCCCCCC}
apa
50
1
167571
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/